FDA Inspection 1262810 — Canan Albayrak, M.D.
The FDA completed an inspection of Canan Albayrak, M.D. on Jan 29, 2025 in Atakum. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 29, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Atakum (Turkey)
Additional Details
Clinical Investigator (CI)